Omega-3 polyunsaturated fatty acids (Omacor) for hypertriglyceridemia

Medical Letter on Drugs and Therapeutics

Volumn 47, Issue 1221, 2005, Pages 91-92

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

ATORVASTATIN; FENOFIBRATE; FLUINDOSTATIN; GEMFIBROZIL; MEVINOLIN; NICOTINIC ACID; OMEGA 3 FATTY ACID; PLACEBO; PRAVASTATIN; ROSUVASTATIN; SIMVASTATIN;

BLEEDING; CLINICAL TRIAL; COST BENEFIT ANALYSIS; DIET SUPPLEMENTATION; DRUG DOSE REGIMEN; DRUG MECHANISM; DYSPEPSIA; ERUCTATION; HUMAN; HYPERGLYCEMIA; HYPERTRIGLYCERIDEMIA; SHORT SURVEY; SIDE EFFECT; TASTE AVERSION; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 33749157581     PISSN: 0025732X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (7)

1. Drugs for lipids. Treat Guidel Med Lett 2005; 3:15.
2. PM Kris-Etherton et al. Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation 2002; 106:2747.
3. R Marchioli et al. Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction: time-course analysis of the results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI)-Prevenzione. Circulation 2002; 105:1897.
4. WS Harris et al. Safety and efficacy of Omacor in severe hypertriglyceridemia. J Cardiovasc Risk 1997; 4:385.
5. HJ Pownall et al. Correlation of serum triglyceride and its reduction by omega-3 fatty acids with lipid transfer activity and the neutral lipid compositions of high-density and low-density lipoproteins. Atherosclerosis 1999; 143:285.
6. PN Durrington et al. An omega-3 polyunsaturated fatty acid concentrate administered for one year decreased triglycerides in simvastatin treated patients with coronary heart disease and persisting hypertriglyceridemia. Heart 2001; 85:544.
7. Most recent data (September 30, 2005) from retail pharmacies nationwide available from NDCHealth, a healthcare information services company.